This 3rd Manufacturing Run Will Incorporate Slight Modifications in Each Ingredient Checklist & Label Design
NEW YORK, NY, Oct. 26, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Firm”), a income producing, diversified life sciences firm, with a proprietary line of purposeful “complement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) in addition to two ongoing Biotechnology initiatives, at the moment introduced plans to start a 3rd manufacturing run of its Cannabidiol (“CBD”) infused Gum Drop product, branded as: Tauri-Gummies™. The Firm is incorporating a slight re-formulation for this 3rd manufacturing run, to enhance this extremely fashionable CBD edibles product. Since its late 2019 introduction, the Firm’s Tauri-Gummies™ product has been highly regarded with its E-Commerce prospects. This gum drop product is manufactured within the format of “Fifties Nostalgic Model” and can be Vegan formulated (Gelatin Free).
The Firm anticipates that this 3rd manufacturing run will probably be comprised of three,000 – 5,000 Jars of Tauri-Gummies™. Every Jar comprises 24 gum drops, with every gum drop infused with 25mg of CBD isolate (600mg CBD per Jar). The gum drops are manufactured in 4 distinct flavors: Cherry (Pink), Orange (Orange), Lemon (Yellow), Lime (Inexperienced).
In different information, the Firm continues to boost the social media presence and model consciousness for its flagship model: Tauri-Gum™. The Firm’s Tauri-Gum™ Instagram Web page (@taurigum), now has greater than 8,200 Followers. The Firm plans to replace shareholders, as soon as the ten,000 Follower(s) threshold is surpassed.
ABOUT TAURIGA SCIENCES INC.
Tauriga Sciences, Inc. (TAUG) is a income producing, diversified life sciences firm, engaged in a number of main enterprise actions and initiatives. The corporate manufactures and distributes a number of proprietary retail merchandise and product traces, primarily centered on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market phase. The primary product line, branded as Tauri-Gum™, consists of a proprietary complement chewing gum that’s Kosher licensed, Halal licensed, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Tauri-Gum™ Taste: Pear Bellini). The Firm’s commercialization technique consists of a broad array of retail prospects, distributors, and a fast-growing E-Commerce enterprise phase (E-Commerce web site: www.taurigum.com). Please go to our company web site, for extra data, in addition to inquiries, at http://www.tauriga.com
Complementary to the Firm’s retail enterprise, are its two ongoing biotechnology initiatives. The primary one pertains to the event of a Pharmaceutical grade model of Tauri-Gum™, for nausea regulation (particularly designed to assist sufferers which can be subjected to ongoing chemotherapy therapy). On March 18, 2020, the Firm introduced that it filed a provisional U.S. patent software overlaying its pharmaceutical grade model of Tauri-Gum™. The Patent, filed with the usP.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second pertains to a collaboration settlement with Aegea Biotechnologies Inc. for the co-development of a speedy, multiplexed, Novel Coronavirus (COVID-19) check with superior sensitivity and selectivity.
On October 6, 2020, the Firm introduced that it has been accepted to function as a U.S. Authorities Vendor (CAGE CODE # 8QXV4)
On October 7, 2020 the Firm disclosed a Strategic Alliance with Suppose BIG, LLC, Social Affect Startup Based by CJ Wallace, Son of Christopher “The Infamous B.I.G.” Wallace.
The Firm is headquartered in New York Metropolis and operates a regional workplace in Barcelona, Spain. As well as, the Firm operates a full time E-Commerce success middle positioned in LaGrangeville, New York.
DISCLAIMER — Ahead-Wanting Statements
This press launch comprises sure “forward-looking statements” as outlined by the Personal Securities Litigation Reform Act of 1995 which characterize administration’s beliefs and assumptions regarding future occasions. These forward-looking statements are sometimes indicated through the use of phrases akin to “could,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and should embody statements relating to company goals in addition to the attainment of sure company targets and milestones. Ahead-looking statements are based mostly on current circumstances and on administration’s current beliefs with respect to occasions that haven’t occurred, that won’t happen, or which will happen with totally different penalties or timing than these now assumed or anticipated. Precise outcomes could differ materially from these expressed in ahead trying statements as a result of identified and unknown dangers and uncertainties, akin to aren’t ensures of normal financial and enterprise situations, the flexibility to efficiently develop and market merchandise, client and enterprise consumption habits, the flexibility to consummate profitable acquisition and licensing transactions, fluctuations in trade charges, and different components over which Tauriga has little or no management. Many of those dangers and uncertainties are mentioned in larger element within the “Threat Elements” part of Tauriga’s Type 10-Ok and different filings made every now and then with the Securities and Trade Fee. Such forward-looking statements are made solely as of the date of this launch, and Tauriga assumes no obligation to replace forward-looking statements to mirror subsequent occasions or circumstances. You shouldn’t place undue reliance on these forward-looking statements.
Tauriga Sciences, Inc.
555 Madison Avenue, fifth Flooring
New York, NY 10022
Chief Govt Officer
Mr. Seth M. Shaw
E mail: email@example.com
cell # (917) 796 9926
Corp. Web site: www.tauriga.com
E-Commerce Web site: www.taurigum.com
Tiger International Administration